25 of the Best Ophthalmologists Near Me in union city, NJ

Dr. Yannuzzi has made numerous innovative and lasting contributions in imaging, drug development, and therapeutic modalities. He was the first to use oral non-steroid anti-inflammatory medication for the treatment of cystoid macular edema and developed an eye drop to treat this condition. He has described new diseases as well as new associations and manifestations of established entities and photosensitization.He has published over 400 scientific papers and 13 books, which have earned him respect and admiration in the ophthalmic-retinal community and retina specialists internationally. He is well recognized as a devoted and excellent educator, a superb clinical diagnostician, and a prolific organizer of retinal meetings worldwide. Dr. Yannuzzi is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Adult-Onset Vitelliform Macular Dystrophy (AVMD), and Vitrectomy.

Joseph Panarelli is an Ophthalmologist practicing medicine in New York, New York. Dr. Panarelli is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Trabeculectomy, and Vitrectomy. Dr. Panarelli is currently accepting new patients.

I specialize in the diagnosis and treatment of patients with ocular tumors, including benign and malignant tumors of the eye. I have been working in this field for more than 20 years. Cancer of the eye is a rare disease, but once the tumor is found we begin the treatment process; the key is to be diagnosed and treated timely and correctly. My goal is to improve the prognosis of these rare eye diseases in terms of life, conservation of the eye and sight. There is a large team dedicated to ocular oncology at Duke Health. I work very closely with colleagues across Duke Eye Center and from Duke Cancer Center, specialists in children and adults, to develop the best diagnosis and treatment plans for patients suffering from cancer of the eye with the mission of providing optimal prognosis for life, eye and vision preservation. Dr. Materin is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Melanoma of the Eye, Metastatic Uveal Melanoma, Uveal Melanoma, Choroid Plexus Carcinoma, and Vitrectomy. Dr. Materin is currently accepting new patients.

Dr. Klancnik utilizes all forms of ophthalmic imaging including fluorescein angiography, indocyanine green angiography, as well as noninvasive forms of imaging such as spectral domain optical coherence tomography, autofluorescence photography, and ultrasonography.Dr. Klancnik is a magna cum laude graduate of Yale University. He earned his medical degree from Jefferson Medical College of Thomas Jefferson University and was elected to the Alpha Omega Alpha and Hobart Amory Hare honor medical societies. He completed his internship at the Lankenau Hospital and his ophthalmology residency at Wills Eye Hospital. He completed his medical and surgical vitreoretinal fellowship at Manhattan Eye, Ear & Throat Hospital and Columbia University. He is an Assistant Professor of Clinical Ophthalmology at New York University School of Medicine.Dr. Klancnik is a member of numerous medical organizations including the American Academy of Ophthalmology, American Society of Retinal Specialists, and Association for Research in Vision and Ophthalmology. He is an author of numerous peer-reviewed journal articles and book chapters and has presented at scientific meetings nationally and internationally. He is active in numerous clinical trials as principle or sub-investigator and serves as a reviewer for several ophthalmology journals. Dr. Klancnik is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), and Retinal Vein Occlusion. Dr. Klancnik is board certified in American Board Of Ophthalmology, Diplomate and United States Medical Licensing Exam; Parts I, II, & III.

Dr. Paul T. Finger has collected or discovered the latest and most advanced medical technologies for the diagnosis and treatment of ocular tumors and eye cancer.With great respect for collaboration, he works closely with you, your referring doctor and his associated specialists to provide the most excellent care possible.The New York Eye Cancer Center was designed to be a responsive and caring environment, we strive to be your and your doctor's first choice for eye cancer care.Dr. Finger is the Director of Ocular Tumor Services at the Manhattan Eye, Ear and Throat Hospital and teaches residents from the New York University School of Medicine.A world-recognized expert in radiation and surgical techniques to conserve the eye and vision; Dr. Finger has pioneered the use of palladium-103 plaque radiation for choroidal melanoma, 3D and high-frequency ultrasound to image intraocular tumors, and created this world-renowned web site. Dr. Finger publishes in the major clinical journals and lectures frequently at local, national and international meetings. He graduated from Tulane Medical School, the Manhattan Eye, Ear and Throat Hospital, and then completed specialty training in treatment of ocular tumors and orbital diseases.Dr. Finger is certified by the American Board of Ophthalmology and is a Fellow of both the American College of Surgeons and the American Academy of Ophthalmology and sees patients from all over the world.Dr Finger was a principal investigator for The Collaborative Ocular Melanoma Study. He Chaired the Ophthalmic Oncology Task Force that wrote the 2014 consensus guidelines for plaque radiationt therapy of choroidal melanoma and retinoblastoma for The American Brachytherapy Society. Dr. Finger was the clinical director for the Plaque Radiation Therapy (Task Group 129) of the American Association for Physicists in Medicine (AAPM). Dr. Finger is Chair of the Ophthalmic Oncology Task Group of The American Joint Committee on Cancer (AJCC) - International Union Against Cancer (UICC). The AJCC-UICC has created a universal language (TNM-classification) commonly used around the world to describe eye cancer.Dr. Finger has a particular interest in melanoma of the choroid, ciliary body and iris. He has written extensively about new ways to detect and treat retinoblastoma, conjunctival melanoma, squamous carcinoma, metastatic cancer to the eye and orbital tumors.Dr. Finger has assembled a team to care for patients with eye tumors. By picking the best doctors from several institutions, his team includes the top radiation, medical and pediatric oncologists from several institutions in New York City.Dr. Finger has spent his career inventing and improving new methods of diagnosis and treatment for eye cancer:. Dr. Finger is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Melanoma of the Eye, Metastatic Uveal Melanoma, Uveal Melanoma, Iridectomy, and Vitrectomy. Dr. Finger is currently accepting new patients.

Brian Marr, MD heads the Ophthalmic Oncology Service at the Harkness Eye Institute. He has comprehensive experience in the diagnosis, treatment, and management of ocular tumors including intraocular tumor resection, laser, radiation, and chemotherapy procedures. He has helped devise thousands of complex treatments for tumors of the eye, eyelid, orbit, and conjunctiva for his adult, children, and infant patients. Currently, Dr. Marr is a collaborator on a Columbia University clinical trial for a first-of-its-kind, new class of drug treatment for uveal melanoma.Dr. Marr is a board-certified ophthalmologist whose work has centered around ophthalmic oncology since 2000. One of the very few ocular oncologists trained in all aspects of eye cancer, Dr. Marr's clinical experience in treating these diseases is among the most extensive in the United States. His interest and experience in ophthalmic oncology began during an eight-year tenure in the Ocular Oncology Service at the Wills Eye Hospital in Philadelphia. There, he gained extensive experience treating intraocular tumors, and tumors of the eyelid, orbit, and conjunctiva in children and adults. It was there that Dr. Marr developed and improved many surgical procedures used to cure cancers of the eye, successfully treated thousands of patients, and helped their families though their battle with eye cancer. Next, Dr. Marr moved on to Memorial Sloan Kettering Cancer Center, where he remain for nine years, starting in 2008.Dr. Marr has some of the greatest experience with intra-arterial chemotherapy for treating retinoblastoma in the country, if not the world, as well as all other forms of retinoblastoma treatment. He has been a key member of many multidisciplinary surgical teams, treating advanced skull base tumors and complex facial skin lesions. He has developed a strong belief and treatment philosophy that the best research be used to help his patients, rather than his best patients be used to help his research. The field of ophthalmic oncology encompasses many rare conditions and his experience helps his patients get the best care and results as quickly as possible. Dr. Marr lectures and consults across the US and abroad, and has authored numerous research articles in the field of ocular oncology. He is the principal investigator in a first-in-class drug study for treating primary uveal melanoma, in an international, multi-center trial. He also volunteers his medical expertise in underserviced parts of the world, such as Nigeria and Indonesia, and has helped train physicians in more than 20 countries. Dr. Marr’s efforts as a contributor to ongoing education in ocular oncology have been recognized by the American Academy of Ophthalmology, where he now serves as chief editor of the Academy’s Oncology and Pathology’s One network. Dr. Marr is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Retinoblastoma, Melanoma of the Eye, Metastatic Uveal Melanoma, Uveal Melanoma, and Vitrectomy. Dr. Marr is board certified in Ophthalmology. Dr. Marr is currently accepting new patients.

Celso Tello is an Ophthalmologist practicing medicine in New York, New York. Dr. Tello is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Glaucoma, Ocular Hypertension (OHT), Cataract, Trabeculectomy, and Vitrectomy. Dr. Tello is board certified in American Board Of Ophthalmology. Dr. Tello is currently accepting new patients.

Sung Park is an Ophthalmologist practicing medicine in New York, New York. Dr. Park is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Glaucoma, Ocular Hypertension (OHT), Cataract, Trabeculectomy, and Iridectomy. Dr. Park is board certified in American Board Of Ophthalmology. Dr. Park is currently accepting new patients.

David Chu is an Ophthalmologist practicing medicine in New York, New York. Dr. Chu is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Uveitis, Scleritis, Interstitial Keratitis, Corneal Transplant, and Cataract Removal. Dr. Chu is board certified in American Board Of Ophthalmology. Dr. Chu is currently accepting new patients.

Kathryn Colby is an Ophthalmologist practicing medicine in New York, New York. Dr. Colby is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Fuchs Dystrophy, Macular Corneal Dystrophy Type 1, Corneal Dystrophy and Perceptive Deafness, Interstitial Keratitis, and Corneal Transplant. Dr. Colby is currently accepting new patients.

Susan Fromer is an Ophthalmologist practicing medicine in New York, New York. Dr. Fromer is highly rated in 24 conditions, according to our data. Her clinical expertise encompasses Glaucoma, Kallikrein Hypertension, Allergic Conjunctivitis, and Meibomianitis. Dr. Fromer is currently accepting new patients.

Philip Ferrone is an Ophthalmologist practicing medicine in Elmhurst, New York. Dr. Ferrone is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Retinal Detachment, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Coats Disease, and Vitrectomy. Dr. Ferrone is board certified in American Board Of Ophthalmology. Dr. Ferrone is currently accepting new patients.

Jasmine Francis is an Ophthalmologist practicing medicine in New York, New York. Dr. Francis is highly rated in 23 conditions, according to our data. Her clinical expertise encompasses Retinoblastoma, Melanoma of the Eye, Metastatic Uveal Melanoma, Vitrectomy, and Liver Embolization. Dr. Francis is currently accepting new patients.

Naomi Goldberg is an Ophthalmologist practicing medicine in New York, New York. Dr. Goldberg is highly rated in 16 conditions, according to our data. Her clinical expertise encompasses Uveitis, Birdshot Chorioretinopathy, Scleritis, and Neuroretinitis. Dr. Goldberg is board certified in American Board Of Ophthalmology. Dr. Goldberg is currently accepting new patients.

Dr. Cooney is a practicing vitreoretinal surgeon who was previously an assistant professor of ophthalmology at Johns Hopkins University and later became the director of the Medical Retina Service, the Duke Center for Macular Degeneration, and the medical retina fellowship program from 2001 to 2005. He received a MBA degree from Kenan-Flagler Business School at the University of North Carolina, Chapel Hill.Dr. Cooney serves as a consultant and advisory board member for several pharmaceutical companies. In 1998, Dr. Cooney helped to establish InnoRx, an ophthalmic drug delivery and pharmaceutical company acquired by SurModics and served as a consultant from 2000 to 2002.Dr. Cooney’s clinical practice focuses on the medical and surgical treatment of vitreoretinal diseases, particularly age-related macular degeneration and diabetic retinopathy. He is actively involved in the clinical development of new diagnostic and therapeutic modalities for vitreoretinal disease and the training of residents and fellows.,Dr. Cooney helped establish InnoRx, an ophthalmic drug delivery and pharmaceutical company acquired by SurModics. Dr. Cooney is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Cone Dystrophy, and Doyne Honeycomb Retinal Dystrophy.

John Seedor is an Ophthalmologist practicing medicine in New York, New York. Dr. Seedor is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Fuchs Dystrophy, Interstitial Keratitis, Corneal Dystrophy and Perceptive Deafness, Corneal Transplant, and Trabeculectomy. Dr. Seedor is board certified in American Board Of Ophthalmology. Dr. Seedor is currently accepting new patients.

David C. Ritterband MD, FACS is a Professor of Ophthalmology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Prior to joining Manhattan Eye, Ear and Throat Hospital (MEETH)/Northwell Eye Institute, he was a Professor of Ophthalmology at the Icahn School of Medicine at Mt Sinai and System Director of the Refractive Surgery Service for the Mount Sinai Health System. At MEETH he has assumed leadership of the Refractive Surgery division and the Laser Vision Correction Center and sees patients at the Manhattan Eye, Ear and Throat Hospital on 64th Street. Dr. Ritterband is a graduate of Duke University and received his medical degree at New York Medical College where he was elected to Alpha Omega Alpha, the national medical honor society. He completed his Ophthalmology Residency at New York Medical College where he was elected Chief Resident. He completed his Corneal and External disease and Refractive Surgery Fellowship at the University of Pittsburgh School of Medicine Eye and Ear Institute. He is a fellow of the American Academy of Ophthalmology and the American College of Surgeons. He is a past president of the Ocular Microbiology and Immunology Group and a long time Medical Board member of the Eye Bank for Sight Restoration in New York City, the world's first Eye Bank. In addition to maintaining a busy tertiary-care referral practice in New York City, Dr. Ritterband is a nationally recognized physician, scientist, and surgeon. He has published over 250 medical and scientific papers, book chapters, monographs, and research abstracts. He has lectured widely in the United States on cornea, cataract, and refractive surgery topics. His clinical and research interests include cornea transplantation, cataract surgery, ocular drug development, laser refractive surgery, and ocular infections. A committed teacher and mentor, he has trained over 50 clinical cornea fellows first at the highly regarded AUPO certified corneal fellowship program at the New York Eye and Ear Infirmary and continuing with the current AUPO corneal fellowship program at Manhattan Eye, Ear and Throat Hospital. Dr. Ritterband has received numerous awards including an Honor Award from the American Academy of Ophthalmology and has been named multiple times to New York Magazine's Best Doctors, Castle Connolly's Top Doctors, and the NY Times Magazine's Super Doctors. In addition, while at the New York Eye and Ear Infirmary he received 6 Resident Outstanding Teaching and Dedicated Service Awards. Dr. Ritterband is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Cataract, Endophthalmitis, Interstitial Keratitis, Corneal Transplant, and Trabeculectomy. Dr. Ritterband is board certified in American Board Of Ophthalmology. Dr. Ritterband is currently accepting new patients.

Steven Odrich is an Ophthalmologist practicing medicine in New York, New York. Dr. Odrich is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Cataract, Glaucoma, Meibomianitis, Dry Eye Syndrome, and Vitrectomy. Dr. Odrich is board certified in American Board Of Ophthalmology. Dr. Odrich is currently accepting new patients.

David Abramson is an Ophthalmologist practicing medicine in New York, New York. Dr. Abramson is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Retinoblastoma, Gliomatosis Cerebri, Hereditary Retinoblastoma, Vitrectomy, and Leg or Foot Amputation. Dr. Abramson is currently accepting new patients.

Amilia Schrier is an Ophthalmologist practicing medicine in New York, New York. Dr. Schrier is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Cataract, Blepharitis, Meibomianitis, Cataract Removal, and Vitrectomy. Dr. Schrier is board certified in American Board Of Ophthalmology. Dr. Schrier is currently accepting new patients.

Dr. Jeffrey M. Liebmann is a Professor of Ophthalmology, Glaucoma Service Director, and Vice-Chair for the Department of Ophthalmology at Columbia University Medical Center.Dr. Jeffrey M. Liebmann graduated from Boston University School of Medicine, completed his ophthalmology residency at the State University of New York/Downstate Medical Center, and his glaucoma fellowship at the New York Eye and Ear Infirmary. Dr. Liebmann serves as Shirlee and Bernard Brown Professor, Vice-Chair, and Director of the Glaucoma Division of the Department Ophthalmology at Columbia University Medical Center. He is a fellow of the American Academy of Ophthalmology, Association for Research in Vision and Ophthalmology and American College of Surgeons. Dr. Liebmann is currently Editor-in-Chief of Journal of Glaucoma, a member of the Board of Governors of the World Glaucoma Association and Board of Directors of The Glaucoma Foundation and Secretary-Treasurer of the New York Glaucoma Society. Dr. Liebmann is a past-President of the World Glaucoma Association, American Glaucoma Society, and the New York Society for Clinical Ophthalmology and was co-founder of the New York Glaucoma Research Institute, the American Glaucoma Society Foundation and ASCRS Glaucoma Day.In addition to maintaining a busy tertiary-care referral practice in New York City, Dr. Liebmann is Principal Investigator for the NIH African Descent and Glaucoma Evaluation Study (ADAGES) and Ocular Hypertension Treatment Study (OHTS III) at Columbia University and is the author and/or co-author of more than 1000 medical and scientific papers, book chapters, and abstracts. He has lectured widely in the United States and abroad on glaucoma diagnosis and management. His current main areas of research interest include the causes of glaucoma, glaucoma progression, glaucoma surgery, ocular imaging, and neuroprotection. Dr. Liebmann is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Trabeculectomy, and Iridectomy. Dr. Liebmann is board certified in Ophthalmology. Dr. Liebmann is currently accepting new patients.

Kyle Godfrey is an Ophthalmologist practicing medicine in New York, New York. Dr. Godfrey is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Thyroid Eye Disease, Eyelid Drooping, Chemosis, Vitrectomy, and Endoscopy. Dr. Godfrey is currently accepting new patients.

"William M. Schiff, MD is a board certified Ophthalmologist, specializing in the medical and surgical management of vitreous and retinal diseases. He is the Director of Ophthalmic Surgery at Manhattan Eye Ear and Throat Hospital (MEETH) and serves an educational role as the Co-Director of the Vitreoretinal Fellowship Program. Dr. Schiff's practice encompasses the management of medical and surgical diseases of the vitreous, retina, and macula including macular degeneration, macular hole, epiretinal membrane, diabetic retinopathy and retinal detachment. Dr. Schiff was previously Professor of Clinical Ophthalmology at Columbia University, College of Physicians and Surgeons. He has lectured widely, has authored or coauthored more than 50 publications, and is an active member of numerous professional societies and organizations including The American Academy of Ophthalmology, The Retina Society, The American Society of Retinal Specialists and the New York Ophthalmologic Society. Dr. Schiff has earned the Achievement Award from the American Academy of Ophthalmology and the Honor's Award from the American Society of Retina Specialists. He has been named in ""New York Magazine's Best Doctors,"" Castle Connolly's ""America's Top Doctors"" and Castle Connolly's ""Top Doctors in the New York Metro Area.""". Dr. Schiff is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Retinal Vein Occlusion, and Retinal Detachment. Dr. Schiff is board certified in American Board Of Ophthalmology. Dr. Schiff is currently accepting new patients.

Dr. George A. (Jack) Cioffi is an internationally recognized glaucoma scientist and clinician and is the Edward S. Harkness Professor and Chair of the Department of Ophthalmology at Columbia University Vagelos College of Physicians and Surgeons since 2012. He also holds the Jean and Richard Deems Endowed Professorship and is the Ophthalmologist-in-Chief at NewYork-Presbyterian Hospital/Columbia University Irving Medical Center. From 2014 to 2023, Dr. Cioffi served as the President of ColumbiaDoctors, the multi-specialty faculty practice organization of more than 2,500 clinicians from Columbia University Irving Medical Center and was concurrently appointed Vice Dean of Clinical Affairs. Dr. Cioffi formerly held the Richard G. Chenoweth Chair of Ophthalmology at the Devers Eye Institute and was the Chief Medical Officer & Senior Vice President at Legacy Health System in Portland, Oregon. He received his medical degree at the University of South Carolina, completed a residency in ophthalmology at the University of Maryland where he also served as Chief Resident, and a fellowship in Research & Clinical Glaucoma at Devers Eye Institute under Dr. E. Michael Van Buskirk. Subsequently, he completed the inaugural Harvard Business School program in Managing Healthcare Delivery.Dr. Cioffi is the Editor-in-Chief of Journal of Academic Ophthalmology, the official journal of the Association of University Professors of Ophthalmology (AUPO). As well, he is Editor Emeritus of the Journal of Glaucoma, after serving for 10 years as the Editor-in-Chief, and he is the past Chair of the Basic and Clinical Science Course for the American Academy of Ophthalmology. He is the Chair of the Scientific Advisory Committee for the Glaucoma Research Foundation in San Francisco. He is a past President of the Oregon Academy of Ophthalmology and has served as a member of the FDA Ophthalmology/Dermatology Advisory Committee for drug approval. He also served on the Board of Directors for the Foundation for Medical Excellence and was selected by the Governor John Kitzhaber to serve on the Oregon Health Policy Board’s Outcomes & Quality taskforce. Dr. Cioffi, a physician for more than 30 years, has published over 250 articles, has enjoyed support from the National Eye Institute of the National Institutes of Health for more than two decades. He has delivered numerous named lectures and has received the Honor Award, the Senior Honor Award and two Secretariat Awards from the AAO. He has mentored more than 50 clinical and post-doctoral fellows over his career. These clinicians and scientists are now at academic institutions and in practices around the U.S., Canada, Europe, Asia, and Australia. Dr. Cioffi is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Trabeculectomy, and Cataract Removal. Dr. Cioffi is board certified in Ophthalmology. Dr. Cioffi is currently accepting new patients.

Dr. Slakter is a native of Los Angeles, California. He graduated from Pomona College in 1979 and was elected to Phi Beta Kappa fraternity and received his Doctor of Medicine degree from Albert Einstein College of Medicine in 1983 and was elected to Alpha Omega Alpha fraternity. He completed residency training in ophthalmology at the Manhattan Eye, Ear & Throat Hospital in 1987 and a year of fellowship training in medical and surgical retinal diseases also at Manhattan Eye, Ear & Throat Hospital in New York. Dr. Slakter is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Choroid Plexus Carcinoma, and Vitrectomy. Dr. Slakter is board certified in Diplomate, American Board Of Ophthalmology and Diplomate, National Board Of Medical Examiners. Dr. Slakter is currently accepting new patients.